
















Supplementary data for article: 
 
 
        Nikolić, S.; Ćirić, I.; Roller, A.; Lukeš, V.; Arion, V. B.; Grgurić-Šipka, S. Conversion of 
Hydrazides into: N, N ′-Diacylhydrazines in the Presence of a Ruthenium(II)-Arene 





Conversion of hydrazides into N,N'-diacylhydrazines in the presence of ruthenium(II)-
arene complex 
Stefan Nikolića, Ivanka Ćirića, Alexander Rollerb, Vladimir Lukesc, Vladimir B. Arionb, 
Sanja Grgurić-Šipkad
aInovative Centre, Faculty of Chemistry, University of Belgrade, Studentski trg 12-16, 11 000 
Belgrade, Serbia
bInstitute of  Inorganic Chemistry, University of Vienna, Währinger Str. 42, 1090 Vienna, 
Austria
cInstitute of Physical Chemistry and Chemical Physics, Slovak University of Technology in 
Bratislava, Radlinského 9, SK-812 37 Bratislava, Slovakia
dFaculty of Chemistry, University of Belgrade, Studentski trg 12-16, 11000 Belgrade, Serbia
* corresponding authors: Email: sanjag@chem.bg.ac.rs; WWW: 
www.chem.bg.ac.rs/osoblje/36-en.html Tel: +381 11 3336 742.
Table of contents
NMR spectra ………………………………………………..……………….Figure S1-14
X-ray Analysis…………………………………………..…………Figure 1-4; Table 1-10
DFT Calculations………………………………………………Figure S15-S16; Table S1
Electronic Supplementary Material (ESI) for New Journal of Chemistry.
This journal is © The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2017
Figure S1. 1H NMR (500 MHz, DMSO-d6) spectrum of H2L2.
Figure S2. 13C NMR (100 MHz, DMSO-d6) spectrum of H2L2
Figure S3. 1H NMR (500 MHz, DMSO-d6) spectrum of H2L3
Figure S4. 13C NMR (100 MHz, DMSO-d6) spectrum of H2L3
Figure S5. 1H NMR (500 MHz, CDCl3) spectrum of 1
Figure S6. 13C NMR (100 MHz, CDCl3) spectrum of 1
Figure S7. 1H NMR (500 MHz, CDCl3) spectrum of 2
Figure S8. 13C NMR (100 MHz, CDCl3) spectrum of 2
Figure S9. 1H-1H COSY NMR (500 MHz, CDCl3) spectrum of 2
Figure S10. 1H-13C HSQC NMR (500 MHz, CDCl3) spectrum of 2
Figure S11. 1H NMR (500 MHz, CDCl3) spectrum of 3
Figure S12. 13C NMR (100 MHz, CDCl3) spectrum of 3
Figure S13. 1H NMR (500 MHz, CDCl3) spectrum of 4
Figure S14. 13C NMR (50 MHz, CDCl3) spectrum of 4
X-ray Analysis
The X-ray intensity data were measured on Bruker D8 Venture diffractometers equipped with 
multilayer monochromators, Mo K/a INCOATEC micro focus sealed tube and Kryoflex II cooling 
device. The structures were solved by direct and patterson methods and refined by full-matrix least-
squares techniques. Non-hydrogen atoms were refined with anisotropic displacement parameters. 
Hydrogen atoms were inserted at calculated positions and refined with a riding model or as rotating 
groups. The following software was used: Frame integration, Bruker SAINT software packagei using a 
narrow-frame algorithm, Absorption correction, SADABSii , structure solution, SHELXS-2013iii, 
refinement, SHELXL-2013iii, OLEX2iv, SHELXLEv, molecular diagrams, OLEX2iv. Experimental data 
and CCDC-code can be found in Table 1. Crystal data, data collection parameters, and structure 
refinement details are given in Tables 2 to 9. Molecular Structure in “Ortep View” is displayed in 
Figure 1 to 4. A overview about “Metal - Ring Geometry” is given in Table 10.
Table 1 Experimental parameter and CCDC-Code.









Bruker [K] [mm] [s] [°]
1 D8 Mo 100 40 2.4 1784 0.4 1492601
2 D8 Mo 100 34 8 1630 0.4 1492600
3 D8 Mo 100 35 5.6 1832 0.4 1492602
4 D8 Mo 100 34 15 2626 0.5 1492599
[RuCl(propionylhydrazine)(η6-p-cymene)]Cl [1] for “New Journal of 
Chemistry”.
Figure 1 Crystal structure of [1], drawn with 50% displacement ellipsoids. Disorder, second moiety of asymmetric unit, 
counter ion and hydrogens omitted for clarity. The degree of main residue disorder is 31%.
Table 2 Sample and crystal data of [1].
Chemical formula C13H22Cl2N2ORu Crystal system monoclinic
Formula weight [g/mol] 788.59 Space group P21/c
Temperature [K] 100 Z 8
Measurement method \Φ and \ω scans Volume [Å3] 3308.2(2)
Radiation (Wavelength 
[Å]) MoKα (λ = 0.71073)
Unit cell 
dimensions  [Å] 
and [°]
13.8233(6) 90
Crystal size / [mm3] 0.297 × 0.195 × 0.08  20.4127(9) 103.2769(16)
Crystal habit clear orange block  12.0459(5) 90
Density (calculated) / 
[g/cm3] 1.583
Absorption 
coefficient / [mm-1] 1.265
Abs. correction Tmin   0.6938 Abs. correction Tmax 0.746
Abs. correction type    multiscan F(000) [e-] 1600
Table 3 Data collection and structure refinement of [1].
Index ranges -16 ≤ h ≤ 16, -24 ≤ k ≤ 24, -14 ≤ l ≤ 14
Theta range for 
data collection [°] 3.626 to 50.698
Reflections number             73955 Data / restraints / parameters 6072/36/414
Refinement method Least squares all data R1 = 0.0353, wR2 = 0.0781
Function minimized Σ w(Fo2 - Fc2)2
Final R indices
 I>2σ(I) R1 = 0.0298, wR2 = 0.0752
Goodness-of-fit on F2 1.06 w=1/[σ2(Fo2)+(0.0428P)2+0.0437P]
Largest diff. peak and 
hole [e Å-3] 0.95/-0.94
Weighting scheme
where P=(Fo2+2Fc2)/3
Ru2Cl2(N1N2-dipropionylhydrazine)(η6-p-cymene)2 [2] for “New Journal of 
Chemistry”.
Figure 2 Grown crystal structure of [2], drawn with 50% displacement ellipsoids. Solvent and hydrogens omitted for clarity. 
Symmetric atoms are tagged with (‘) and are equivalent to 2-X,-Y,1-Z. 
Table 4 Sample and crystal data of [2].
Chemical formula C30H50Cl2N2O4Ru2 Crystal system triclinic
Formula weight [g/mol] 775.76 Space group P-1
Temperature [K] 100 Z 1
Measurement method \Φ and \ω scans Volume [Å3] 813.93(6)
Radiation (Wavelength 
[Å]) MoKα (λ = 0.71073)
Unit cell 
dimensions  [Å] 
and [°]
9.0536(4) 88.9010(11)
Crystal size / [mm3] 0.253 × 0.214 × 0.11  9.0906(4) 88.7726(11)
Crystal habit clear orange block  9.9218(4) 85.6563(11)
Density (calculated) / 
[g/cm3] 1.583
Absorption 
coefficient / [mm-1] 1.128
Abs. correction Tmin   0.7056 Abs. correction Tmax 0.746
Abs. correction type    multiscan F(000) [e-] 398
Table 5 Data collection and structure refinement of [2].
Index ranges -12 ≤ h ≤ 12, -12 ≤ k ≤ 12, -13 ≤ l ≤ 13
Theta range for 
data collection [°] 4.494 to 60.216
Reflections number             24472 Data / restraints / parameters 4777/0/187
Refinement method Least squares all data R1 = 0.0153, wR2 = 0.0390
Function minimized Σ w(Fo2 - Fc2)2
Final R indices
 I>2σ(I) R1 = 0.0149, wR2 = 0.0387
Goodness-of-fit on F2 1.058 w=1/[σ2(Fo2)+(0.0183P)2+0.4424P]
Largest diff. peak and 
hole [e Å-3] 0.55/-0.75
Weighting scheme
where P=(Fo2+2Fc2)/3
Ru2Cl2(N1N2-dibutanoylhydrazine)(η6-p-cymene)2 [3] for “New Journal of 
Chemistry”.
Figure 3 Asymmetric Unit of [3], drawn with 50% displacement ellipsoids. Hydrogen atoms omitted for clarity. Co 
crystalized [RuCl2(6-p-cymene)]2 light blue shaded and grown over center of symmetry °. 
Table 6 Sample and crystal data of [3].
Chemical formula C38H56Cl4N2O2Ru3 Crystal system triclinic
Formula weight [g/mol] 1017.85 Space group P-1
Temperature [K] 100 Z 2
Measurement method \Φ and \ω scans Volume [Å3] 1983.18(14)
Radiation (Wavelength 
[Å]) MoKα (λ = 0.71073)
Unit cell 
dimensions  [Å] 
and [°]
9.9160(4) 76.1322(15)
Crystal size / [mm3] 0.189 × 0.129 × 0.055  12.3781(5) 78.3310(15)
Crystal habit clear orange block  16.9971(7) 88.3137(16)
Density (calculated) / 
[g/cm3] 1.705
Absorption 
coefficient / [mm-1] 1.433
Abs. correction Tmin   0.9349 Abs. correction Tmax 1
Abs. correction type    numerical F(000) [e-] 1028
Table 7 Data collection and structure refinement of [3].  
Index ranges -11 ≤ h ≤ 11, -14 ≤ k ≤ 14, -20 ≤ l ≤ 20
Theta range for 
data collection [°] 2.52 to 50.7
Reflections number             49197 Data / restraints / parameters 7252/0/453
Refinement method Least squares all data R1 = 0.0236, wR2 = 0.0513
Function minimized Σ w(Fo2 - Fc2)2
Final R indices
 I>2σ(I) R1 = 0.0206, wR2 = 0.0498
Goodness-of-fit on F2 1.057 w=1/[σ2(Fo2)+(0.0253P)2+1.7685P]
Largest diff. peak and 
hole [e Å-3] 1.21/-0.45
Weighting scheme
where P=(Fo2+2Fc2)/3
Ru2Cl2(N1N2-dipentanoylhydrazine)(η6-p-cymene)2 [4] for “New Journal of 
Chemistry”.
Figure 4 Asymmetric Unit of [4], drawn with 50% displacement ellipsoids. Hydrogen atoms, disorder and free water 
omitted for clarity. The degree of main residue disorder is 13%.
Table 8 Sample and crystal data of [4].
Chemical formula C30H50Cl2N2O4Ru2 Crystal system triclinic
Formula weight [g/mol] 775.76 Space group P-1
Temperature [K] 100 Z 2
Measurement method \Φ and \ω scans Volume [Å3] 1658.71(14)
Radiation (Wavelength 
[Å]) MoKα (λ = 0.71073)
Unit cell 
dimensions  [Å] 
and [°]
9.6072(5) 95.264(2)
Crystal size / [mm3] 0.164 × 0.164 × 0.067  9.7722(5) 90.7653(18)
Crystal habit clear orange block  17.7727(8) 93.160(2)
Density (calculated) / 
[g/cm3] 1.553
Absorption 
coefficient / [mm-1] 1.107
Abs. correction Tmin   0.7093 Abs. correction Tmax 0.746
Abs. correction type    multiscan F(000) [e-] 796
Table 9 Data collection and structure refinement of [4].  
Index ranges -13 ≤ h ≤ 13, -13 ≤ k ≤ 13, -25 ≤ l ≤ 25
Theta range for 
data collection [°] 4.592 to 60.19
Reflections number             92947 Data / restraints / parameters 9735/32/428
Refinement method Least squares all data R1 = 0.0458, wR2 = 0.0824
Function minimized Σ w(Fo2 - Fc2)2
Final R indices
 I>2σ(I) R1 = 0.0337, wR2 = 0.0747
Goodness-of-fit on F2 1.063 w=1/[σ2(Fo2)+(0.0249P)2+3.7315P]
Largest diff. peak and 




Table 10 Metal - Ring Geometry for Compounds 1-4
Metal - Ring Geometry
Compound Center Perpendicular Projection of Heavy Atom Ring Centroid Ring-Slippage
  [Å] [Å] [Å]
1 Ru1A 1.6461(10)  1.6459(4) 0.027
 Ru1B - - -
2 Ru1  1.6610(5) 1.6605(2) 0.041
3 Ru1A 1.6760(9) 1.6759(3) 0.014
 Ru1B 1.6587(9)  1.6580(3) 0.048
4 Ru1A 1.6600(11) 1.6595(3) 0.041
 Ru1B 1.6668(11) 1.6668(3) 0.005
Disordered solutions are, because of constraints and restraints, excluded from detailed analysis
i Bruker SAINT V8.32B Copyright © 2005-2016 Bruker AXS
ii Sheldrick, G. M. (1996). SHELXS, SHELXL. University of Göttingen, Germany.
iii Sheldrick, G.M. (2008). Acta Cryst. A64, 112-122.
iv Dolomanov, O.V., Bourhis, L.J., Gildea, R.J, Howard, J.A.K. & Puschmann, H. , OLEX2, (2009), J. Appl. Cryst. 42, 339-
341
v C. B. Huebschle, G. M. Sheldrick and B. Dittrich, ShelXle: a Qt graphical user interface for SHELXL, J. Appl. Cryst., 44, 
(2011) 1281-1284
DFT Calculations 
–11505.4890094 (R1) –342.9131381 (R2)
–11848.4142065 (Ia) –11848.4120083 (Ib)
–11387.701511 (IIa) –11387.6682279 (IIb)
Figure S15. The B3LYP optimal structures of studied reactants, intermediates and product. 
The electronic B3LYP energies are in hartree.
–10926.993142 (IIIa) -10926.97686 (IIIb)
–11269.8755261 (IVa) –11269.8701989 (IVb)
–11269.8893666 (V)
–11158.145344 (P)
Figure S15. (continued) The B3LYP optimal structures of studied reactants, intermediates 
and product. The electronic B3LYP energies are in hartree.











C=O 1.282 / 1.283 1.287 / 1.290(2)
Ru–O 2.077 / 2.075 2.095 / 2.069(14)
Ru–Cl 2.439 / 2.439 2.412 / 2.412(5)
C9–C10 1.417 / 1.425 1.410 / 1.407(3)
C9–C10´ 1.419 / 1.427 1.435 /1.427(3)
C10–C11 1.428 / 1.428 1.421 / 1.420(3)
C10´–C11´ 1.419 / 1.421 1.403 / 1.402(3)
C11–C12 1.423 / 1.421 1.412 / 1.409(3)
C11´–C12 1.432 / 1.428 1.435 / 1.433(3)
C9–C13 1.502 / 1.503 1.503 / 1.500(3)
C12–C14 1.527 / 1.519 1.517 / 1.518(3)
C14–C15 1.538 / 1.532 1.528 / 1.520(3)
C14–C15´ 1.534 / 1.542 1.539 / 1.528(3)
Figure S16. The selected B3LYP bond lengths in angstroms and atom labeling
